Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
- PMID: 25114518
- PMCID: PMC4124048
- DOI: 10.2147/CIA.S62642
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
Abstract
As a result of increased life expectancy, octogenarians constitute an increasing proportion of patients admitted to hospital for ST-segment elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention is currently the treatment of choice for octogenarians presenting with STEMI. The recent literature on this topic has yielded controversial results, even though advances in drug-eluting stents and new types of antithrombotic agents are improving the management of STEMI and postoperative care. In this paper, we review the current status of percutaneous coronary intervention in the elderly with STEMI, including the reasons for their high mortality and morbidity, predictors of mortality, and strategies to improve outcomes.
Keywords: ST-segment elevation myocardial infarction; octogenarians; percutaneous coronary intervention.
Similar articles
-
Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).Am J Cardiol. 2014 Jun 1;113(11):1794-801. doi: 10.1016/j.amjcard.2014.03.007. Epub 2014 Mar 15. Am J Cardiol. 2014. PMID: 24837256
-
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.Circ Cardiovasc Interv. 2014 Aug;7(4):543-51. doi: 10.1161/CIRCINTERVENTIONS.114.001360. Epub 2014 Jun 17. Circ Cardiovasc Interv. 2014. PMID: 24939928 Clinical Trial.
-
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005. JACC Cardiovasc Interv. 2015. PMID: 25616924
-
Outcome of Percutaneous Coronary Intervention in Old Patients Presenting with Acute Coronary Syndrome.Arch Iran Med. 2022 Aug 1;25(8):523-532. doi: 10.34172/aim.2022.84. Arch Iran Med. 2022. PMID: 37543874 Review.
-
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.J Am Heart Assoc. 2020 Jun 16;9(12):e015263. doi: 10.1161/JAHA.119.015263. Epub 2020 Jun 1. J Am Heart Assoc. 2020. PMID: 32476540 Free PMC article.
Cited by
-
In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.ARYA Atheroscler. 2016 Jan;12(1):28-34. ARYA Atheroscler. 2016. PMID: 27114734 Free PMC article.
-
Short and Long-Term Clinical Outcomes in Octogenarian Patients With Non-ST-Elevation Myocardial Infarction: A Comparative Analysis of Revascularization Strategies Versus Medical Management.Cureus. 2024 Jan 1;16(1):e51430. doi: 10.7759/cureus.51430. eCollection 2024 Jan. Cureus. 2024. PMID: 38298307 Free PMC article.
-
Characteristics, Treatment, and In-Hospital Outcomes of Older Patients With STEMI Without Standard Modifiable Risk Factors.JACC Asia. 2023 Nov 21;4(1):73-83. doi: 10.1016/j.jacasi.2023.09.013. eCollection 2024 Jan. JACC Asia. 2023. PMID: 38222256 Free PMC article.
-
Elderly patients with myocardial infarction selected for conservative or invasive treatment strategy.Clin Interv Aging. 2015 Jan 21;10:321-7. doi: 10.2147/CIA.S74012. eCollection 2015. Clin Interv Aging. 2015. PMID: 25653514 Free PMC article.
-
Clinical efficacy of different treatments and their impacts on the quality of life of octogenarians with coronary artery disease.Chin Med J (Engl). 2019 Nov 20;132(22):2657-2663. doi: 10.1097/CM9.0000000000000504. Chin Med J (Engl). 2019. PMID: 31725445 Free PMC article.
References
-
- Centers for Disease Control and Prevention MMWR series on public health and aging. MMWR Morb Mortal Wkly Rep. 2003;52(6):101–116. - PubMed
-
- Singh M, Mathew V, Garratt KN, et al. Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic. Am J Med. 2000;108(3):187–192. - PubMed
-
- Newell MC, Henry JT, Henry TD, et al. Impact of age on treatment and outcomes in ST-elevation myocardial infarction. Am Heart J. 2011;161(4):664–672. - PubMed
-
- Yang X, Zhao Y, Wu H, et al. The coexistence of comorbidities at admission is an independent predictor of 30-day mortality of patients hospitalized with acute myocardial infarction: analysis of 5523 cases in China. Int J Cardiol. 2012;155(3):451–452. - PubMed
-
- Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115(19):2570–2589. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials